The Specification of Glycinergic Neurons and the Role of Glycinergic Transmission in Development by Chalphin, Alexander V. & Saha, Margaret S.
Frontiers in Molecular Neuroscience  www.frontiersin.org  April 2010  | Volume 3  |  Article 11  |  1
MOLECULAR NEUROSCIENCE
REVIEW ARTICLE
published: 22 April 2010
doi: 10.3389/fnmol.2010.00011
tegmentum (Flint et al., 1998). More recently Scain et al. (2010) 
have described non-synaptic glycine signaling in the embryonic 
spinal cord.
A complete understanding of glycinergic transmission must 
entail knowledge of how cells acquire a glycinergic phenotype and 
the role of glycinergic signaling in development. This review sum-
marizes the current understanding of glycinergic signaling in devel-
opment. First, we examine the literature detailing the expression 
patterns of the molecular components of the glycinergic phenotype 
and glycinergic signaling in various vertebrate model organisms 
over the course of CNS development. Next we consider the molecu-
lar mechanisms governing the expression of glycinergic phenotype 
markers and the glycinergic phenotype. Finally, we review the cur-
rent literature on the functional role of glycine signaling in the 
developing nervous system and then conclude with an overview 
of areas for further research.
DEVELOPMENTAL EXPRESSION PATTERNS OF GLYCINERGIC 
PHENOTYPE MARKERS
In vertebrates the biosynthesis of glycine for use in neurotrans-
mission and general cellular metabolism is mediated by an enzyme 
differentially referred to as glycine synthase and glycine cleav-
age enzyme. This enzyme catalyzes a readily reversible reaction 
between carbon dioxide, ammonium ion, N5, N10-methylene 
tetrahydrofolate, NADH and a proton to form glycine, tetrahy-
drofolate and NAD+. Immunohistochemistry and in situ hybridi-
zation experiments in rats have shown that the glycine cleavage 
system enzyme complex is expressed in embryonic neural stem/
progenitor cells, neuroepithelial cells, and astrocytes (Ichinohe 
et al., 2004).
INTRODUCTION
In addition to its role in protein metabolism as the structurally 
simplest amino acid, glycine also serves as an important and 
widely distributed inhibitory neurotransmitter in the nervous sys-
tem of animals from several phyla (Werman et al., 1968; Sawada 
et al., 1980, 1984; Mladinic et al., 1999 reviewed in Walker and 
Holden-Dye, 1991; Walker et al., 1996). While its role in adult 
neurotransmission is relatively well characterized, less is known 
about glycinergic signaling during development. Previous work 
has focused on examining the developmental expression of the 
glycine receptor and transporters as well as glycine immunore-
activity as a means of discerning the process whereby cells adopt 
a glycinergic phenotype. However several recent studies have 
begun to elucidate the mechanisms governing the development 
of the glycinergic phenotype as well as the role of glycine in neural 
development. For example, synaptic release of both glycine and 
GABA has been shown to play a determinative role in the proper 
development of many motor and sensory pathways, including 
those necessary for audition, vision, respiration, and nociception 
(Kirsch, 2006). Disruption of glycinergic transmission during neu-
ral development has also been shown to cause hyperekplexia, a 
disorder characterized by exaggerated startle responses, hypertonia 
and episodic neonatal apnea (Eulenburg et al., 2006; Rees et al., 
2006). Differential expression of GlyR subunits over the course 
of development (namely α2) have been observed, although the 
function of such embryonic GlyRs have not yet been determined 
(Young-Pearse et al., 2006). Some evidence suggests that glycine 
has an early “pre” neuronal function, where taurine may act as an 
endogenous ligand in non-synaptic embryonic GlyR signaling to 
help coordinate the early neocortex, hippocampus and ventral 
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cells and in ﬁ  bers at the edges of the marginal zone. One day later 
glycine IR begins to appear in the dorsal horn, intensify in cells 
in the ventral horn, and decrease in the marginal zone. By E16.5 
IR reaches near adult levels in both the ventral and dorsal horns. 
These investigators also observed the colocalization of GABA and 
glycine IR in a third of all glycine positive cells, with the glycinergic 
system maturing a day after the GABA system (Allain et al., 2006; 
Sibilla and Ballerini, 2008).
Glycine IR in the mammalian retina has also been extensively 
studied. Immunostaining for glycine of the rat retina revealed the 
presence of the neurotransmitter in cells of the ventricular zone 
and the retinal pigmented epithelium (RPE) from birth. These cells 
extended processes to the neuroblastic layer of the outer retinal 
edge, indicating that they may be developing bipolar or amacrine 
cells. IR positive cells were seen migrating through the ventricular 
zone by day postnatal day 4 (P4), when subpopulations of glycine 
positive amacrine cells were ﬁ  rst observed in the inner plexiform 
layer (IPL). Over the next 2 days the amacrine cells of the IPL 
became less diffuse at the IPL borders and expression decreases in 
the RPE. Near adult expression is ﬁ  nally achieved by P11 (Fletcher 
and Kalloniatis, 1997).
Glycine IR has also been examined in chick embryos with 
positive staining ﬁ  rst observed on E8 in the dorsal and ventral 
grey matter of chick embryos. The number of positive cells rises 
sharply 2 days later and reaches near adult expression by day 12. 
The majority of the IR positive neurons were observed in the dorsal 
horn lamina IV, V and VI. Glycine positive cells were also observed 
in the lamina VII and diffusely distributed throughout the spinal 
grey matter. In chick embryos, similar to mammals, GABA appears 
4 days earlier than glycine, and is observed in the ventral horn and 
does not share the same distribution as glycine IR cells in the spinal 
grey matter (Berki et al., 1995).
Amphibian embryos have served as a classic model system for 
examining the development of the glycinergic phenotype (Roberts 
et al., 1988). In Xenopus laevis the ﬁ  rst glycine positive IR cells 
appear in the rostal spinal cord and caudal hindbrain intermediate 
between ventral and dorsal at stage 22, a few hours after the neural 
tube closes. Glycine expression extends caudally while the more ros-
tral regions in-ﬁ  ll as the embryo matures. At stage 25 only unipolar 
glycine IR cells were observed, but axons and growth cones can be 
easily visualized by stage 27. Neuron numbers can be accurately 
quantiﬁ  ed up to stage 27, after which time the concentration of 
glycine positive cells can exceed 30 per 100 µm. By stage 37 (swim-
ming tadpole stages), glycine IR in the spinal cord is mostly dorsal, 
with clear axons descending ventrally (Roberts et al., 1988).
Because of its unique phylogenetic position as a jawless ﬁ  sh, 
lamprey has been the focus of comparative expression studies for 
neurotransmitter markers including glycine. Glycine IR was ﬁ  rst 
observed in the caudal rhombencephalon at E5, followed by the 
diencephalon of early prolarvae and then the mesencephalon by 
P15. Within these areas, glycine immunostaining occurred in CSF-c 
cells of the preoptic nucleus and postoptic-buberal cell group, 
post-optic commissural region, ventral and dorsal thalamus, pre-
tectum, and M5 nucleus of Schober. IR was seen in the isthmic, 
trigeminal, and octaval levels of the ventrolateral neuropil and the 
vagal region of the caudal rhombencephalon. At this late prolarval 
stage, glycine was observed in the proptic nucleus, hypothalamus, 
In addition to glycine itself, glycinergic transmission requires 
several additional molecular components. Two membrane-bound 
proteins, GlyT1 and GlyT2, members of the Na+/Cl− dependent neu-
rotransmitter transporter family, serve to reuptake glycine from the 
synaptic cleft back into cells, with GlyT1 expressed predominantly 
by glial cells and GlyT2 serving as the primary neuronal glycine 
transporter. In addition, the vesicular inhibitory amino acid trans-
porter (VIAAT), also commonly referred to as VGAT, transports 
both GABA and glycine into synaptic vesicles for later release into 
the synapse. Both GlyT2 and VIAAT must both be expressed for a 
cell to successfully perform as a glycinergic neuron.
The signaling function of glycine is mediated mainly by the 
glycine receptor (GlyR), a strychnine-sensitive member of the nico-
tinic acetylcholine receptor (nAChR) super family that is a ligand-
gated chloride anion channel (reviewed in Betz and Laube, 2006). 
GlyR is a pentameric protein with a stochiometry reported ﬁ  rst 
as 2α/3β (Becker et al., 1988; Kuhse et al., 1993; Burzomato et al., 
2003) and more recently as 3α/2β using a combined site directed 
mutagenesis and homology modeling approach (Grudzinska et al., 
2005). Four α subunits (α1, α2, α3, and α4) and one β subunit have 
been characterized to date. The α2 and α4 subunits are expressed 
earlier in development compared to α1 and α3, which are generally 
only seen in the adult brain (Kuhse et al., 1991). Expression of α2 is 
observed before synaptogenesis, suggesting this subunit may play 
a role in pre-synaptic glycine signaling. Splice variants have also 
been observed for the α1, α2 and α3 subunits. The α1 splice vari-
ant (α1ins) includes eight additional amino acids and is expressed 
in the brainstem and spinal cord of mature rats (Kuhse et al., 1991; 
Malosio et al., 1991a). The α2 splice variants (α2A and αB) dif-
fer by expression of two homologous exons and are both limited 
to expression in the early developing CNS (Grenningloh et al., 
1990). Another α2 variant (α2*) is not generated through alter-
native splicing and has yet to be completely characterized (Kuhse 
et al., 1990). The α3 splice variant α3L has a very similar primary 
structure to α3 while the splice variant α3K lacks a 15 amino acid 
sequence. Both α3 splice variants are observed in the human fetal 
brain (Nikolic et al., 1998; reviewed in Legendre, 2001). While the 
exact role of the α and β subunits in agonist binding is unclear 
(Grudzinska et al., 2005), binding between the large cytoplasmic 
loop of the β subunit and the anchoring protein gephyrin has been 
well characterized (Kneussel et al., 1999). Gephyrin binding has 
been implicated in synaptogenesis, but uncertainty still remains 
over the necessity of gephyrin for synapse formation (Feng et al., 
1998; Meier et al., 2000; Levi et al., 2004). In order to understand 
the process by which cells adopt a glycinergic phenotype, investi-
gators have conducted numerous studies examining the ontogeny 
and developmental expression patterns of each of these molecular 
components in a variety of different species.
GLYCINE
The presence of glycine immunoreactivity (IR) in neuronal and 
glial cells has served as the primary marker for the development 
of the glycinergic phenotype and has been the subject of devel-
opmental expression studies in a number of different organisms, 
particularly in mammals. In mice, Allain et al. (2006) observed little 
IR before embryonic day 12.5 (E12.5) in the mouse spinal cord, at 
which time glycine IR was visualized in the somata of ventral horn Frontiers in Molecular Neuroscience  www.frontiersin.org  April 2010  | Volume 3  |  Article 11  |  3
Chalphin and Saha  Glycinergic transmission in development
thalamus, pretectum and the nucleus of the medial longitudinal 
fascicle, mesencephalon, isthmus and rhombencephalon. Later in 
the true larvae stage, glycine IR was found in olfactory bulb, preop-
tic nucleus, oculomotor nucleus, dorsal isthmic gray and isthmic 
reticular formation. GABA and glycine appear to co-localize in 
the M5 nucleus, reticular formation, and dorsal column nucleus 
during larval stages (Villar-Cervino et al., 2009). In the lamprey 
retina, glycine IR is ﬁ  rst seen in the inner plexiform layer during 
early metamorphosis stages (M1). Near-adult expression, including 
IR in the inner and outer plexiform layers, inner and outer nuclear 
layers and the horizontal cell layer, is seen by late transformation 
stages (M6) (Abalo et al., 2008). Many taxa and areas of the CNS 
remain to be assayed for glycine IR, making comparing expression 
patterns between organisms difﬁ  cult. The data currently available 
in mice, chick and frogs suggests that glycine ﬁ  rst appears in the 
spinal cord after GABA across all three taxa. In the retina, on the 
other hand, differences in the life cycles of mice and lamprey, the 
two species assayed for glycine IR in the retina, prevents much 
comparison. The lamprey undergoes a maturation process where 
they can remain functionally blind larvae for up to 8 years before 
adulthood (Villar-Cervino et al., 2009).
GLYCINE TRANSPORTERS
Given the somewhat problematic nature of distinguishing between 
the amino acid glycine present in all cells and the low levels of neu-
rotransmitter-speciﬁ  c glycine at early stages of development using 
immunohistochemistry, detection of glycine transporter expression 
at the mRNA and/or protein level has served as a valuable tool for 
analyzing the development of the glycinergic phenotype. GlyT1 
and GlyT2 immunostaining are observed earliest in the mouse 
and rat at E10 in the midbrain ﬂ  oor plate and E12, respectively. 
By E17 two areas of GlyT1 expression are visible at the borders 
between the thalamus and hypothalamus and the border between 
the dorsal thalamus and zona incerta. GlyT2 levels rise in the ven-
tral white matter of the spinal cord at E14 and then in the dorsal 
funiculus, reticular formation, spinal trigeminal nucleus, thalamus, 
cerebellum, colliculi and central tegmental tract at E17 (Jursky and 
Nelson, 1996). A study focusing on the auditory system observed 
GlyT2 IR develop from no staining at E18 to positive staining in 
all brainstem nuclei by P4. Next perisomatic and increased punc-
tate signal developed in all brainstem nuclei except the inferior 
colliculus and medial geniculate body. Immunostaining decreased 
across the auditory system after P10 and adult expression levels 
were achieved within 4 weeks of birth (Friauf et al., 1999). In the rat 
spinal cord GlyT1 is ﬁ  rst observed at E11 in the ventral ventricular 
zone. Immunostaining for VIAAT (VGAT) in the mouse retina 
conﬁ  rms that glycinergic neurons appear in a similar pattern to 
the rat retina. IR occurs in the inner retina by P1, the outer retina 
by P3 and P5 in mouse and rat respectively, and adult expression 
in both by P11 (Johnson et al., 2003).
In lower vertebrates glycine transporters have generally been 
analyzed at the mRNA rather than the protein level. Higashijima 
et al. (2004) ﬁ  rst observed glycinergic neurons in the zebraﬁ  sh 
Danio rerio via in situ hybridization against GlyT2 in the mediodor-
sal domain of the rostral spinal cord 20-h post-fertilization (hpf). 
These results are consistent with the ﬁ  rst appearance of rhythmic 
ﬁ  ring in interneurons of the dorsal spinal cord believed to be caused 
by glycinergic neurons. Brain expression was not observed until 
3-day postfertilization (dpf), where a stark line is observed in the 
rostral hindbrain near rhombomeres 1 and 2. Some very weak 
expression is also seen in the ventral midbrain at this stage. Near 
complete expression was observed by this group by four dpf.
The other glycine transporter, GlyT1, is expressed in the hind-
brain and spinal cord of the developing zebraﬁ  sh in a non-over-
lapping pattern. In Situ hybridization using GlyT1 speciﬁ  c probe 
reveals that the transporter is expressed in the rostral spinal cord 
by at least 18 hpf. By 24 hpf GlyT1 expression is observed in ﬁ  ve 
dorsal stripes in the hindbrain and along the dorsal midline of the 
caudal hindbrain and spinal cord. By the next day (48 hpf) the 
transporter is observed along the dorsal midline of the midbrain, 
hindbrain and spinal cord and the ﬂ  oor plate cells of the hindbrain 
and spinal cord. At 72 hpf hindbrain expression spreads but remains 
mostly dorsal and superﬁ  cial. The strongest signal in the hindbrain 
at this point is along the ventricle border. The medial, ﬂ  oor plate, 
and dorsal midline cells of the spinal cord also begin to express 
GlyT1 at this point (Cui et al., 2005).
Expression studies in Xenopus laevis have revealed the appear-
ance of GlyT1 ﬁ  rst in the proliferative ventricular zone and interme-
diate zone of the midbrain, the ventricular layer of the hind brain, 
and the intermediate region of the anterior spinal cord during early 
tailbud stages (stage 24). By the time the tadpole can swim GlyT1 
appears in the forebrain, retina, somites and blood islands. GlyT2 
and VIAAT are initially expressed earlier than GlyT1 in the anterior 
spinal cord of the late neurula (stage 21). By stage 33 GlyT2 is found 
in the lateral forebrain, medial midbrain and mid-dorsal region 
of the spinal cord. VIAAT is expressed more widely slightly earlier 
(stage 27). Expression for the vesicular transporter is observed in the 
ventral and lateral regions of the telencephalon, the dorsal, ventral, 
and midpoint of the dorsal–ventral axis in the diencephalon and 
the intermediate zone of the spinal cord. VIAAT mRNA was also 
detected in ventral Kolmer-Agduhr cells of the spinal cord (Wester 
et al., 2008). Other investigators have shown that GlyT1 and GlyT2 
are expressed in the ganglion and inner nuclear layers of the frog 
(Rana pipiens) and rat retinas (Pena-Rangel et al., 2008).
GLYCINE RECEPTOR
While no systematic analysis of all four GlyRα subunits and the β 
subunit has been conducted, there are several reports using immu-
nohistochemistry and in situ hybridization for various subunits 
in some model species. Early immunostaining for GlyR in the rat 
supports glycinergic expression elucidated through glycine IR. The 
α1 subunit is ﬁ  rst seen in the rat spinal cord at E14, after which time 
mRNA signal steadily increases in the ventral and dorsal horns until 
leveling off at P15. In the brain α1 is detected at near adult by P5. At 
E15 the α2 subunit is expressed in the telencephalon, diencephalon, 
midbrain and the ﬁ  rst layer of the cortex, and remains through early 
postnatal stages (P5). Layers I, II and IV are all strongly labeled by 
P5, and adult expression is achieved by P15 with the addition of 
staining to layer VI. The remaining GlyR subunit, α3, is not observed 
until relatively late in development (P5), but remains throughout 
life. Initially the colliculi of the reticular thalamic nucleus are sig-
niﬁ  cantly stained, followed much later by the cerebellum at P40. 
The α3 subunit is not heavily expressed in the spinal cord, but is 
seen in both ventral and dorsal horns between E19 and P20. The β Frontiers in Molecular Neuroscience  www.frontiersin.org  April 2010  | Volume 3  |  Article 11  |  4
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subunit of GlyR is ﬁ  rst expressed at E14 in both the telencephalon 
of the brain and the ventral and dorsal horns of the spinal cord. 
Although adult expression is accomplished quickly after E14 in the 
spinal cord, brain expression of the β subunit is more dynamic. At 
E19 the ﬁ  rst two layers of the cortex, septum, Ammon’s horn of 
the hippocampal formation, thalamus and midbrain are stained. 
Adult expression, now including the VI layer of the cortex, entorhi-
nal cortex, hippocampus and subiculum occurs by P15 (Malosio 
et al., 1991b). The postnatal rat retina shows GlyR expression in 
the neuroblastic layer, while GlyR in the adult is only observed in 
the inner nuclear layer (INL) (Sassoe-Pognetto and Wassle, 1997). 
Young and Cepko (2004) have also shown that GlyR and speciﬁ  -
cally GlyRα2 are expressed in retinal progenitor cells at birth. GlyR 
is differentially expressed in OFF cone bipolar cells, but not ON 
cone bipolar cells. GlyR with α1 subunits was observed uniformly 
on the dendrites of parasol and midget ganglion cells in the same 
study (Grunert, 2000).
In the developing chick retina immunoreactivity against GlyR 
does not appear in the IPL until E12. The adult GlyR subunit α1 
is not observed until E16 when it is seen punctate at synapses, 
suggesting that subunit expression is variable over the course of 
development (Hering and Kröger, 1996).
Immunohistochemistry against GlyRα2 and GlyRα3 shows 
distinct expression in the adult Xenopus laevis retina, while 
GlyRα1immunostaining shows no expression. GlyRα2 expression 
is observed mostly in the IPL, consisting of a thin, horizontal distal 
band and a broader, proximal horizontal band. Some scattered 
puncta are also observed in the INL. Similar patterns are seen with 
GlyRα3 immunostaining in the IPL, although scattered puncta are 
also detected in the OPL (Vitanova, 2006).
Although no detailed immunohistochemistry or in situ hybridi-
zation studies have been conducted for GlyRβ in Zebraﬁ  sh, Hirata 
et al. (2005) did perform a series of RT-PCR assays for GlyRβ1 and 
GlyRβ2 over the course of embryonic CNS development. They 
found that GlyRβ1 is ﬁ  rst expressed by the end of the ﬁ  rst day of 
development, while GlyRβ2 is expressed ﬁ  rst at day 3. GlyRβ1 is 
expressed in repeating bilateral clusters of cells in the hindbrain 
extensively expressed in the spinal cord at the end of the ﬁ  rst day, 
with expression increasing and expanding through the second 
day (Hirata et al., 2005). In situ hybridization for GlyRα2 mRNA 
revealed expression at day one, but no expression at day two in 
optical sections of the spinal cord. GlyRα1 is also expressed in the 
spinal cord during the ﬁ  rst day of embryonic development, but then 
increases in intensity in the spinal cord by day two (McDearmid 
et al., 2006). mRNA for the GlyRα2 subunit was observed in the 
outer nuclear layer of the adult zebraﬁ  sh retina, but studies have 
not been conducted for these mRNAs more widely throughout the 
developing organism (Imboden et al., 2001).
COLOCALIZATION AND COMPARATIVE EXPRESSION PATTERNS
The co-localization and comparative expression kinetics of glycine 
and GABA present an under examined dimension of glycine’s role 
in development. In general, the expression of glycinergic mark-
ers mirrors that of GABAergic markers. GABA tends to appear 
earlier and reach mature expression earlier than glycine, while 
glycine occasionally replaces GABA as the predominant inhibi-
tory neurotransmitter (Allain et al., 2006). Immunostaining in 
the rat brain for GABA and glycine, for example, revealed a stark 
transition from GABA to glycine neurotransmission in the lat-
eral superior olive. Co-expression of both GABAergic and gly-
cinergic markers also change during development. In the mouse 
hypoglossal nucleus, for instance, 30% of GlyR positive cells are 
also IR for γ2GABAAR at E17, a statistic that increases to 50% 
by P30 (Muller et al., 2004). The opposite transition appears in 
the lamprey, presenting one of the most signiﬁ  cant differences in 
expression yet observed among chordates (Villar-Cervino et al., 
2009). Both glycinergic and glutamatergic neurons are associated 
with rhythmic ﬁ  ring patterns, and as expected are both observed 
in the same areas of the developing zebraﬁ  sh spinal cord, albeit 
not lo-localized on the cellular level. Before 30 hpf GlyT2 and the 
GABAergic marker glutamic acid decarboxylase (GAD) are co-
localized in the majority of IR positive neurons for either marker. 
After 30 hpf most neurons become either glycinergic or GABAergic 
(Higashijima et al., 2004). Glutamate appears to be dominant in 
immature P6 amacrine cells, while glycine IR is observed in most 
adult amacrine cells (Fletcher and Kalloniatis, 1997). In the rat 
spinal cord synaptic co-localization of GlyR and GABA recep-
tors occur at numerous layers. Gao et al. (2001) suggest that this 
redundant expression, combined with the observation that these 
amino acids are stored in the same synaptic vesicles, indicates 
a synergistic function of the two neurotransmitters that could 
help ﬁ  ne tune synaptic integration. In the rat retina, GABA and 
glycine immunostaining reveals co-localization in a minority of 
amacrine cells (Fletcher and Kalloniatis, 1997). Todd et al. (1996) 
take the question of co-localization a step further and examined 
the relationship between presynaptic glycine and GABA, and 
postsynaptic GlyR and GABA receptors in the rat spinal cord. 
This group reports that the observed co-IR for presynaptic gly-
cine and GABA and postsynaptic gephyrin (as a marker for GlyR) 
and GABA receptors supports GABA and glycine cotransmission. 
Studies on GABA receptors alone, however, reveal no relationship 
between presynaptic input and aggregation of GABA receptors 
in rat hippocampal cells or cerebellar granule cells (Nusser et al., 
1996, 1998; Kannenberg et al., 1999; Rao et al., 2000).
Taken together, these numerous studies of the expression pat-
terns of glycinergic neurons in the developing vertebrate nervous 
system demonstrate similar emergence across lineages (see Table 1). 
Glycinergic neurons tend to appear during embryonic develop-
ment in the rostral spinal cord, followed by increased expression 
caudally down the spinal cord and rostrally into the hindbrain, 
midbrain and retina. Although there are indications of differen-
tial regulatory mechanisms even between closely related species 
(Jursky and Nelson, 1996), this general pattern is maintained. These 
observations suggest that, despite small changes in the mechanisms 
organizing the distribution of glycinergic neurons, these neurons 
likely perform similar functions during the formation of later 
neural networks.
GLYCINE IN INVERTEBRATES
It was long believed that glycinergic neurotransmission was 
an almost purely vertebrate phenomenon. Walker et al. (1996) 
reported that no evidence has been found for glycinergic trans-
mission in the nematodes, arthropods or annelids. Until relatively 
recently it was thought that the cnidarians lacked the ability to use Frontiers in Molecular Neuroscience  www.frontiersin.org  April 2010  | Volume 3  |  Article 11  |  5
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glycine as a neurotransmitter (Grimmelikhuijzen et al., 2002). 
It is now   suspected that many phyla from the simple hydra to 
our own primate lineage use similar classical neurotransmit-
ters (including glycine) that ﬁ  rst evolved 1000 million years ago 
(reviewed in Walker and Holden-Dye, 1991; Walker et al., 1996). 
Some notable exceptions include nematodes and insects, neither 
of which have functional glycine receptors and instead use GABA 
or glutamate to mediate inhibitory neurotransmission (Ui-Tei 
et al., 1995; Bargmann, 1998). Although evidence for functional 
GlyRs in these groups has yet to appear, Drosophila appear to 
possess 25–30 genes for GABA/glycine receptors and C. elegans 
appear to possess 10 receptor genes (Yoshihara et al., 2001). In 
2001 the ﬁ  rst cnidarian glycine receptors were identiﬁ  ed and 
characterized via biochemical and behavioral studies in Hydra 
vulgaris. These receptors were found to mirror the function of 
vertebrate glycine receptors; they are sensitive to both glycine 
and taurine, which can displace previously bound strychnine 
(Pierobon et al., 2001). Tino et al. (2005) began the process of 
cloning and expressing H. vulgaris glycine receptors. Glycine also 
appears to play a role in the coelenterate pacemaker system, where 
Table 1 | Summary of embryonic and early postnatal expression patterns for glycinergic markers.
Region Lamprey Zebraﬁ  sh Frog Chick Mouse Rat
Spinal cord N/A GlyT2: 
mRNA 
rostral spinal 
cord 20 HPF; 
rostral 2/3rds 
spinal cord 4 
DPF
Glycine IR: rostal 
SC, caudal HB, St. 
22 
GlyT2: mRNA 
rostral SC, St. 21 
VIAAT: mRNA 
rostral SC, St. 21
Glycine IR: 
Parikarya 
(E8); Increase 
at E10
Glycine IR: dorsal 
and ventral horn 
(E12.5); adult 
levels by E16.5 
GlyT1: mRNA in 
ventral ventricular 
zone (E11)
GlyT1: mRNA ventral 
ventricular zone E11; adult 
levels soon after P0 
GlyRα1: mRNA 
ventral+dorsal horns E14 
GlyRα3: mRNA 
ventral+dorsal horn E19 
through P20 GlyRβ: mRNA 
ventral+dorsal horns E14
Brain GlycineIR: caudal 
rhombencephalon 
E5; prosencephalon 
P2; diencephalon 
and 
mesencephalon, 
P15; widespread in 
true larval through 
adult stages.
GlyT2: 
mRNA 
rostral HB 
and ventral 
MB 3DPF
GlyT1: mRNA 
MB+HB/HB St. 24; 
FB+MB+HB St.27 
GlyT2: mRNA 
MB+HB/HB St.31; 
FB+MB+HB low 
levels St. 33 
VIAAT: mRNA 
MB+HB/HB St. 24; 
FB+MB+HB St.27
N/A GlyT1: IR midbrain 
ﬂ  oor plate E10; 
borders of 
thalamus/MB+HB 
E17; adult levels 
after P5 
GlyT2: IR borders 
of thalamus/
MB+HB E17; all 
brainstem nuclei 
by P4; adult levels 
after P5
GlyRα1: mRNA near adult 
by P5 
GlyRα2: mRNA 
telencephalon, 
diencephalon, MB, cortex 
P5 
GlyRα3: mRNA colliculi of 
RTN P5, cerebellum P40 
GlyRβ: mRNA FB, MB E19
Retina Glycine IR: IPL, 
M1; ONL, OPL, 
HCL, INL, IPL, M6
GlyRα1: 
mRNA ONL 
of adult 
VIAAT: mRNA INL 
St.27 
GlyT1: mRNA INL, 
ONL 
GlyT2: mRNA INL, 
ONL
GlyR: IR IPL 
E12
VIAAT: IR inner 
retina P1; outer 
retina P3; adult by 
P7
Glycine IR: ventricular zone 
and RPE/RPC P0; 
neuroblastic layer P4; 
amacrine cells P6; adult 
levels P11 
GlyT1: mRNA INL, ONL 
adult 
GlyT2: mRNA INL, ONL 
adult 
VIAAT: IR inner retina P1; 
outer retina P5; adult by P7 
GlyRα1: IR ganglion cells 
adult 
GlyRα2: mRNA ventricular 
zone + RPE/RPC + IR 
neuroblastic layer P0; only 
INL in adult
Summary of embryonic and adult expression patterns of glycinergic markers.
SC, spinal cord; HB, hind brain; IR, immunoreactivity; RPE, retina pigment epithelium; ONL, outer nuclear layer; OPL, outer plexiform layer; HCL, horizontal cell layer; 
INL, inner nuclear layer; IPL, inner plexiform layer; RTN, reticular thalamic nucleus; M, metamorphosis stage; HPF , hours postfertilization; DPF , days postfertilization; 
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it functions to inhibit endodermal pacemakers through glycine 
receptor binding and excite the pacemakers through NMDA 
receptor interactions (Ruggieri et al., 2004). In the adult glycin-
ergic neurotransmission has been implicated in mouth opening 
during feeding (Pierobon et al., 2001, 2004). Kehoe et al. (2009) 
used sequence data from Aplysia 2-cys-loop gated chloride ion 
channels from Aplysia, a member of the platyhelminthes line-
age to suggest that glycinergic neurotransmission may occur in 
this group. Glycinergic neurotransmission among invertebrates 
overall is poorly understood, and many more phyla must be 
examined before a complete picture of the evolution of this neu-
rotransmitter can be developed.
DETERMINATION OF THE GLYCINERGIC PHENOTYPE
While expression pattern data has provided essential information 
on when the glycincergic phenotype emerges during embryonic 
development, the molecular mechanisms governing the proc-
ess remain poorly understood. The glycinergic neurotransmit-
ter phenotype requires the expression of the transporters GlyT2 
and VIAAT for proper neurotransmission (reviewed in Betz and 
Laube, 2006). In part this is attributable to the fact that the gly-
cinergic phenotype is so closely associated with the GABAergic 
phenotype. Both types of neurons use the same vesicular trans-
porter VIAAT to mediate accumulation of the neurotransmitter 
into synaptic vesicles. GlyT2, however, plays an important role 
in switching between speciﬁ  c neurotransmitter phenotypes. In 
fact, Aubrey et al. (2007) observed increased release of glycine in 
neuroendocrine serotonergic BON cells made to express one of 
the two glycine transporters in a series of experiments using a 
novel double sniffer patch clamp technique. The neural glycine 
transporter GlyT2 also appeared to be more efﬁ  cient than the 
glial glycine transporter GlyT1. By using Caenorhabditis elegans, 
a species which does not use glycinergic neurotransmission, 
these investigators were able to show that increasing cytosolic 
glycine plays an important role in switching neurotransmitter 
speciﬁ  cation.
The speciﬁ  city of the GlyT2 for the neuronal glycinergic phe-
notype provides another approach for analyzing the molecular 
mechanisms mediating the speciﬁ  cation of this neurotransmit-
ter phenotype, namely “working backwards” employing a reverse 
genetic approach through analysis of the upstream regulatory 
regions of the gene. The regulatory mechanisms of these termi-
nal differentiation genes have been partially elucidated in some 
model species. Most of the work on the transcriptional regulation 
of GlyT2 has been conducted in the mouse and rat (Adams et al., 
1995; Ponce et al., 1998; Ebihara et al., 2004). Ponce et al. (1998) 
report three GlyT2 transcriptional isoforms in the rat and Ebihara 
et al. (2004) report three other GlyT2 transcriptional isoforms in 
the mouse, each driven by an alternative promoter. GlyT2a is ﬁ  ve 
amino acids shorter than the GlyT2b isoform at the N-terminal, 
and is able to accumulate glycine in COS. The GlyT2b isoform 
appears to only be able to exchange glycine. Zeilhofer et al. (2005) 
have developed transgenic mice with EGFP expression glycinergic 
neurons by using a BAC vector with 105 kb of 5’ ﬂ  anking DNA and 
21 kb of 3’ ﬂ  anking DNA from the GlyT2 gene. To date no detailed 
functional studies of the GlyT2 promoter have been conducted in 
any model organism.
Another promising approach for unraveling the mechanism 
of glycinergic speciﬁ  cation has been an analysis of various tran-
scription factors whose expression correlates with that of GlyT2, in 
particular Ptf1a, Lbx1 and Pax2 (Figure 1). Investigations of Ptf1a, 
Lbx1, and Pax2 by Huang et al. (2008) were used to generate a model 
of the relationship between these three transcription factors in the 
dorsal spinal cord. Experiments on null mice embryos for combina-
tions of these factors show that all three factors are necessary for 
expression of the glycinergic phenotype. Developing dorsal horn 
neurons in Ptf1a null embryos fail to express GlyT2 from E12.5 
through E16.5 and Pax2−/− mice also fail to express GlyT2 properly 
from E12.5 through E18.5. GlyT2 production was observed, albeit at 
reduced intensity in Lbx1 homozygous negative mice. While these 
transcription factors clearly play a powerful role in the developing 
dorsal horn they did not appear necessary in the ventral horn. Over-
expression experiments of these transcription factors also resulted 
in the development of ectopic inhibitory neurons producing either 
glycine or GABA. These studies also showed that Lbx1 alone is able 
to induce switching from GABAergic to glycinergic speciﬁ  cations. 
According to these authors Ptf1a appears to act as a master regula-
tor of developing inhibitory neurons of the dorsal spinal cord, and 
can act in conjunction with Lbx1 to activate Pax2 as a downstream 
target. Pax2, in turn, has been shown to activate transcription of 
GlyT2 and other differentiation targets. Ptf1a has also been shown 
to play a role in the development of GABAergic and glycinergic 
cells in other areas of the CNS, including horizontal and amacrine 
cells of the mouse retina and glycinergic neurons of the cochlear 
nucleus. Recombination-based lineage tracing suggests that the 
transcription factor is expressed in precursors of both retinal cell 
types. Inactivation of Ptf1a prevents differentiation of horizontal 
and amacrine cells during retina development (Nakhai et al., 2007). 
Ptf1a null mouse embryos fail to develop inhibitory GABAergic 
and glycinergic neurons and Atoh1 null embryos fail to develop 
excitatory glutamatergic neurons in the cochlear nucleus(Fujiyama 
et al., 2009).
Batista and Lewis (2008) have also examined the role of Pax2, 
including both of its isoforms (Pax2a and Pax2b) and Pax8 in gly-
cinergic differentiation. They showed that expression of each of any 
of these three transcription factors leads most often to adoption 
of the glycinergic phenotype. Morpholino knockdown of these 
transcription factors supported the redundant role of Pax2a/b and 
Pax8, as the glycinergic speciﬁ  cation is not lost unless all three tran-
scription factors are knocked down. Lhx1 and Lhx5 are expressed 
in inhibitory interneurons of the dorsal spinal cord and have been 
shown to increase expression of Pax2. Knockdown of Lhx1 and 
Lhx5 results in decreased expression of VIAAT, although they do 
not appear to be obligatory determinant of inhibitory neural phe-
notypes and appear to play no direct role in determining GlyT2 
expression (Pillai et al., 2007). Neuron restrictive silencing factor 
has been shown to act as a repressor of the GlyRα1 subunit through 
binding to the 5’ region of the GlyRα1 mRNA in studies of small-
cell lung cancer cell-derived cell lines (Gurrola-Diaz et al., 2003; 
Neumann et al., 2004).
Speciﬁ  cation of glycinergic amacrine in the retina appears to 
involve the homeobox gene Barhl2. Immunostaining of the devel-
oping retina for the transcription factor by Mo et al. (2004) revealed 
positive IR in both postmitotic amacrine and ganglion cells. Forced Frontiers in Molecular Neuroscience  www.frontiersin.org  April 2010  | Volume 3  |  Article 11  |  7
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as to increase the prevalence of glycinergic neurons, glycinergic 
currents can be detected on muscle cells (Borodinsky and Spitzer, 
2006). There is even some evidence that calcium activity can over-
ride some other genetic differentiation signals, as HNK-1 or lim-3 
positive cells could be induced to adopt the GABAergic or glycin-
ergic phenotype by experimental inhibition of calcium transients 
(Spitzer et al., 2004).
THE ROLE OF NONSYNAPTIC GLYCINE DURING 
DEVELOPMENT
GlyR subunits α2 and β are expressed very early in the develop-
ing rat cerebral cortex (E14-P5) (Malosio et al., 1991b). While 
glycine levels in the cerebral cortex at this time are thought to 
be too low to allow normal neurotransmission (van den Pol and 
Gorcs, 1988; Zafra et al., 1995), the amino-sulfonic acid taurine 
is highly expressed and was hypothesized to act as a ligand for 
the receptor (Smith et al., 1992). Flint et al. (1998) found evidence 
supporting the hypothesis that taurine functions as a ligand for 
GlyR via nonsynaptic signaling in the early neocortex. Indeed, kit-
tens deprived of prenatal taurine develop smaller brains that fail 
to differentiate normally (Palackal et al., 1986). Since 1998 evi-
dence for nonsynaptic taurine-GlyR signaling has been found in 
the rat auditory cortex, hippocampus and dopaminergic neurons 
of the ventral tegmentum and most recently in the spinal cord 
(Mori et al., 2002; Wang et al., 2005; Scain et al., 2010). Mori et al. 
(2002) observed that pressure application of glycine onto hippoc-
ampal CA3 pyramidal cells exposed to antagonists for   ionotropic 
expression of Barhl2 resulted in more frequent differentiation of 
retinal progenitor cells into amacrine or ganglion cells, while domi-
nant-negative studies by the same group yielded fewer amacrine 
and ganglion cells. No changes in GABAergic cell populations were 
seen during these experiments by Mo et al. (2004) but a later group 
(Ding et al., 2009) reported changes in GABAergic populations that 
mirrored changes in glycinergic populations when Barhl2 levels 
were experimentally modulated. Atoh7 and Pou4f2-null retina 
experiments caused down-regulation of Barlh2, suggesting these 
two factors act upstream of Barlh2 (Ding et al., 2009). Bumsted-
O’Brien et al. (2007) demonstrate that another transcription factor, 
Meis2, may also be involved in glycinergic speciﬁ  cation of mouse 
and human amacrine cells; cells that adopt a glycinergic fate repress 
Meis2 while GABAergic cells maintain high Meis2 levels, a result 
which suggests that Meis2 may be a repressor of glycinergic fates.
Over the past decade an increasing body of evidence has accumu-
lated suggesting that neurotransmitter speciﬁ  cation may be inﬂ  u-
enced by activity based mechanisms and environmental factors. It 
has been suggested that Ca+2 transients may inﬂ  uence the adop-
tion of a neurotransmitter phenotype (reviewed in Spitzer, 2006). 
Certain patterns of Ca+2 spiking and frequency have been correlated 
with glutamate, glycine, GABA and acetylcholine neurotransmit-
ter phenotypes. Increased calcium activity is associated with the 
inhibitory neurotransmitters, while high activity is associated with 
excitatory. Glycine receptors are found on embryonic Xenopus laevis 
muscle cells, but expression decreases during the course of normal 
development. If calcium transients are experimentally altered so 
Transcription Factors Involved in Glycinergic Specification
Lhx1 Lhx5
VIAAT
Lbx1 Ptf1a
Pax2a/b
GlyT2
Pax8 NRSF
GlyR α1
Glycinergic 
Phenotype
Barhl2
Atoh7/Pou4f2
Meis2
?
FIGURE 1 | A model for the roles of transcription factors Ptf1a, Lbx1, Pax2a/
b, Pax8, Lhx1, Lhx5 and NRSF in regulating terminal differentiation genes 
of glycinergic neurons based upon current literature cited in text. Lbx1 and 
Ptf1a act together to control Pax2-dependent expression of VIAAT and GlyT2. 
Pax8 acts redundantly with Pax2 on GlyT2, while Lhx1 and Lhx5 also up-regulate 
VIAAT. NRSF down regulates the α1 subunit of GlyR and does not appear to act 
on either GlyT2 or VIAAT. Atoh7 and Pou4f2 both act upstream of Barhl2. The 
exact mechanism of this interaction is unknown, as is the target of Barhl2.Frontiers in Molecular Neuroscience  www.frontiersin.org  April 2010  | Volume 3  |  Article 11  |  8
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 glutatmate and GABAB caused currents. These responses were asso-
ciated with increased chloride conductance and could be halted by 
treatment with the glycine receptor antagonist strychnine. Together 
these results suggest the presence of functional GlyR in the early 
hippocampus, yet no evidence was found connecting these strych-
nine-sensitive chloride currents to synaptic stimulation. Mori et al. 
(2002) also found that the application of the β-alanine and tau-
rine uptake inhibitor guanidinoethanesulfonic acid indicated that 
the modulation of these transporters could regulate tonic GlyR 
activation. Studies of rats aged 1–13 days found more evidence of 
nonsynaptic glycine signaling in dopaminergic neurons of ventral 
tegmentum acute brain slices. Currents were observed in current 
clamped neurons after the application of 0.01–0.03 mM taurine via 
interaction with non-synaptic GlyRs (Wang et al., 2005), provid-
ing additional support for non-synaptic or “preneural” glycinergic 
transmission. Outside of the brain, nonsynaptic glycine signaling 
was recently observed in the radial cells of the spinal cord using an 
outside-out sniffer technique measuring glycine release between 
E12.5 and E14. This signaling is attributed to glycine itself and 
not taurine, which is was not observed in immunostained radial 
cells at this stage of development. Radial cells were also observed 
to release glycine upon mechanical stimulation and to produce 
spontaneous rhythmic behavior in nearby immature neurons. To 
fully prove the existence of a nonsynaptic glycine signaling sys-
tem endogenous glycine release must be demonstrated in addi-
tion to expression of functional GlyR (Scain et al., 2010).It must 
also be noted that the studies in support of nonsynaptic glycine 
signaling are limited due to the pharmacological tools used in the 
studies. Guanidinoethanesulfonic acid, for example, blocks tau-
rine transporter and is a GABAA receptor agonist, while sarcosine 
blocks GlyT and serves as a co-agonist for NMDA receptor and a 
full agonist for GlyR (Mangin et al., 2002; Zhang et al., 2009a,b). 
While the role of non-synaptic glycine signaling remains somewhat 
unclear, if not controversial, there is compelling evidence demon-
strating a determinative role for glycinergic signaling during the 
early stages of synapse and network formation in the spinal cord, 
brain, and retina.
THE ROLE OF GLYCINE IN NEURAL DEVELOPMENT
THE ROLE OF GLYCINE IN SPINAL CORD DEVELOPMENT
Glycinergic neurotransmission develops ﬁ  rst in the spinal cord. 
Immature neural circuits of the developing spinal cord can spon-
taneously generate synchronous rhythmic activity patterns that can 
be classiﬁ  ed as central pattern generators (CPGs) if they include 
multiple processes that act in an ascending and descending manor 
that successfully returns to a starting point. CPGs are often associ-
ated with rhythmic respiration, swallowing, and early locomotion. 
These spontaneous bursts can be caused by several neurotransmit-
ters, including the normally inhibitory neurotransmitters GABA 
and glycine. Experiments using the GlyR antagonist strychnine and 
L-type Ca+2 blockers on spinal neurons suggest that GlyR activa-
tion leads to Ca+2 transients that in turn cause accumulation of the 
anchoring protein Gephyrin and GlyR. Taken together these results 
support an activity-driven model for synapse formation (Kirsch 
and Betz, 1998). Young neurons, which do not yet express the K+/
Cl− co-transporter KCC2, typically have higher internal chloride 
ion concentrations when compared to the exterior of the cell, so 
activation of glycine dependent chloride channels results in depo-
larization instead of hyper-polarization observed in mature neu-
rons (Reichling et al., 1994; Rivera et al., 1999). In some instances 
GABA and glycine have been shown to be active at the same synapse 
(Singer and Berger, 2000; Gao et al., 2001).
GlyR has been implicated in regulating interneuron differentia-
tion in the zebraﬁ  sh spinal cord. Targeted knockdown of the GlyR 
embryonic subunit α2 resulted in disruption of rhythm-generating 
networks and an increase in the number of mitotic cells (McDearmid 
et al., 2006). Studies using GlyR and GABAA receptor antagonists 
found that GABAergic and glycinergic synapses each have unique 
roles in modulating locomotion rhythms. Glycine functions to stabi-
lize patterns of alternating rhythms (Hinckley et al., 2005). Although 
GABA may have a stronger role in the maturation of locomotor 
circuitry, glycine becomes the main neurotransmitter responsible for 
mediating reciprocal coupling between mature antagonistic motor 
centers in the mouse spinal cord (Sibilla and Ballerini, 2008).
Glycine transporters have also been shown to play an impor-
tant role in CPG development. Hanson and Landmesser (2004) 
used strychnine to block or slow spontaneous rhythmic ﬁ  ring 
produced by glycinergic neurons. They showed that spontaneous 
bursting activity is necessary for motoneurons to make their ﬁ  rst 
dorsal/ventral pathﬁ  nding decisions, perhaps due to differential 
expression of EphA4 and polysialic acid on NCAM. Later the same 
group (Hanson and Landmesser, 2006) used sarcosine to block 
GlyT1 activity and modulate spontaneous rhythmic ﬁ  ring. These 
investigators found that altering burst frequency disrupted dorsal/
ventral and anterior/posterior pathﬁ  nding decisions of lumbosacral 
motoneurons. Mutant motor phenotypes such as mutant EphA4 
and ephrinB3 mice are also being utilized to shed light on nor-
mal neural development in the spinal cord. Addition of sarcosine 
returned the mutant synchronous activation pattern back to nor-
mal alteration, thus indicating that the balance between excitation 
and inhibition over the midline was shifted toward excitation in 
mutants (Kullander et al., 2001, 2003).
One of the most therapeutically interesting aspects of glycine 
neurotransmission in the spinal cord is its role in the develop-
ment of nociception. Proper formation of pain perception path-
ways requires GABAA receptors and GlyRs in the dorsal horn. It 
has been shown that reducing GlyR synaptic inhibition can lead 
to hypersensitivity to pain (Ahmadi et al., 2002; Coull et al., 2003). 
Harvey et al. (2004) have shown that GlyRα3, which is expressed 
in the superﬁ  cial laminae of the mouse dorsal horn, plays a piv-
otal role in inﬂ  ammatory pain sensitization by demonstrating that 
prostaglandin E2-induced synaptic inhibition is completely abol-
ished in GlyRα3−/− mice. Although most inhibitory synapses are 
GABAergic in rodent neonates, the balance shifts in favor of gly-
cinergic synapses during maturation (Baccei and Fitzgerald, 2004). 
GlyR and the glycine transporters GlyT1 and GlyT2 are currently 
being investigated as pharmacological targets for the treatment of 
pain disorders (reviewed in Dohi et al., 2009).
THE ROLE OF GLYCINE IN BRAIN DEVELOPMENT
The role of glycinergic neurotransmission in the brain presents a 
more complex story that is far from fully understood. Although 
certain areas have seen heavy research, such as the lateral   superior 
olive, many have yet to be pursued in depth. Development of Frontiers in Molecular Neuroscience  www.frontiersin.org  April 2010  | Volume 3  |  Article 11  |  9
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neurons adopt adult  inhibitory neurotransmission. This new stage 
again mirrors a change in the maturation of LSO neural networks; 
synaptic pruning. It is hypothesized that the change in the surviv-
ability of dendrite arbors is connected to the change in glycinergic 
transmission.
The theme of postsynaptic potential switching during neu-
ral circuit modeling is observed in numerous instances over the 
course of development. Glycinergic neurotransmission has been 
shown to inﬂ  uence neural maturation via similar mechanisms in 
the respiratory brainstem nuclei, hippocampus, and the LSO of 
the auditory system (Ben-Ari, 2001). It is unclear how many other 
neural pathways glycinergic signaling may inﬂ  uence (Young-Pearse 
et al., 2006).
THE ROLE OF GLYCINE IN RETINAL DEVELOPMENT
Glycinergic transmission and GlyR mediated taurine signaling have 
been shown to play important roles in embryonic and early postna-
tal retinal development. GlyR mediated taurine signaling has been 
implicated in directing the proliferation of rod photoreceptor cells, 
while glycinergic transmission has been shown to be important to 
light-dependent maturation of retinal ganglion cells and bipolar 
cells. Studies in chicks and rats have given varied results, indicat-
ing that the glycine’s function in retinal development may not be 
well conserved between taxa (Berki et al., 1995; Sassoe-Pognetto 
and Wassle, 1997).
Overexpression of GlyR subunit α2 leads to the development 
of double the percentage of rod photoreceptors at the expense of 
Muller glial cells. Mutation studies of the gene for the GlyR β subu-
nit had little effect on the outer retina, photoreceptors or bipolar 
cells. These results indicate the importance of the α2 subunit in 
taurine signaling. Inhibition of taurine uptake by guanidinoethyl-
sulfate and introduction of exogenous taurine both resulted in 
an increased percentage of photoreceptor cells in the mature 
retina. It is unclear exactly how GlyR mediated taurine signaling 
directs rod photoreceptor cell differentiation. Since no increased 
cell death is observed in GlyRα2 over expression experiments, it 
is thought that GlyR mediated taurine signaling causes cells to 
exit the mitotic cycle, only to later adopt the rod photoreceptor 
phenotype. Taurine’s ability to directly induce rod photorecep-
tor cells regardless of mitotic state via GlyR activation remains 
untested. In addition to taurine signaling, it has been shown that 
rod photoreceptor cell differentiation requires a combination of 
GABA and glycine. The pharmacology of this interaction is yet 
to be determined (Sassoe-Pognetto and Wassle, 1997; Young and 
Cepko, 2004).
The role of glycinergic transmission in the development of gan-
glion cells has been investigated using a line of mutant mice known 
as spastic. These mice possess an insertion of the transposable ele-
ment (LINE1) in the 5th intron for the β subunit gene of GlyR, 
causing aberrant mRNA splicing (Kingsmore et al., 1994; Mulhardt 
et al., 1994). Although mutations in this gene appeared to have few 
effects on photoreceptors or bipolar cells, the β subunit appears to 
be important in the development of retinal ganglion cells. Xu and 
Tian (2008) found that retinal ganglion cells failed to form properly 
in the center through the sublamina a of the inner plexiform layer 
of the retina. These investigators also observed the same pattern of 
mis-expression in normal mice raised in light-deprived conditions. 
  respiratory neural circuits has long been known to involve inhibi-
tory neurotransmission and glycine in particular. Although it is 
unclear if glycine is absolutely required for the generation of basic 
breathing rhythms in neonate rodents, there is strong evidence 
that glycine plays a role in modulating and patterning. Respiratory 
rhythms are not abolished by application of glycine or GABA 
antagonists or alteration of extracellular chloride ion concentra-
tions (Onimaru et al., 1990). Experimentally introduced exogenous 
glycine can, however, augment the frequency and amplitude of 
respiratory rhythms. Conversely, mice without functional GlyT1 
are unable to breathe properly at birth and die within the ﬁ  rst day. 
The strong connection between glial glycine and respiration may 
be mediated via suppression of NMDA receptor function, although 
experimental evidence in support of this hypothesis has yet to be 
gathered (Gomeza et al., 2004). The investigation of the exact role 
of glycinergic neurons in the development of this system has been 
confusing and contradictory. Some investigators have reported that 
glycine causes hyperpolarization and depression of respiration in 
the neonatal spinal cord and brainstem, which is surprising given 
the lack of KCC2 channel expression before E19 in rats to form 
the [K+] necessary to drive such activity (Brockhaus and Ballanyi, 
1998; Ren and Greer, 2006). Others have found that glycine causes 
depolarization of neurons involved in respiration in the develop-
ing medulla (Ritter and Zhang, 2000). Ren and Greer (2006) have 
proposed that these discrepancies may be due to differences in [K+]0 
used in each of these studies.
The developing hippocampus appears to utilize excitatory 
glycinergic signaling for proper neural network formation. The 
adult inhibitory neurotransmitters GABA and glycine have been 
implicated in giant depolarizing potentials (GDPs) in the hippoc-
ampus in studies on rats, rabbits and rhesus macaques. GDPs are 
associated with changes in intracellular Ca+2 transients, especially 
the CA3 region. Observation of GDPs in hippocampal slices from 
these species suggests that glycine may play an important role in 
hippocampal network formation across mammal lineages (Prida 
et al., 1998; reviewed in Ben-Ari, 2001).
The central auditory system is one of the best characterized 
examples of glycinergic neurotransmission in the developing 
mammalian brain. The lateral superior olive (LSO) is one of the 
ﬁ  rst stations in the ascending auditory pathway. The LSO receives 
excitatory inputs from the cochlear nucleus and inhibitory inputs 
from the medial nucleus of the trapezoid body in the adult. From 
fetal stages through postnatal day 7 in gerbils and rats glycinergic 
transmission results in excitatory postsynaptic potentials. This 
period of dual excitatory input occurs during an important stage 
of neuronal growth and strengthening of dendritic arbors (Sanes 
and Friauf, 2000). A growing body of evidence is connecting this 
period of glycine induced depolarization with LSO network matu-
ration via modulating intracellular Ca+2 concentrations (Malenka 
and Nicoll, 1993; Sanes and Friauf, 2000). Kandler et al. (2002) 
have demonstrated that glycinergic inputs of the LSO at this stage 
can induce increased Ca+2 concentrations and action potentials 
using calcium imaging techniques. More recently Kullmann and 
Kandler (2008) showed that subthreshold synaptic responses 
result in local changes in Ca+2 concentration, while suprathresh-
old responses elicit global Ca+2 modulations throughout the den-
drites of the postsynaptic cell. Seven days after birth glycinergic Frontiers in Molecular Neuroscience  www.frontiersin.org  April 2010  | Volume 3  |  Article 11  |  10
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Together these results suggest that the mechanism connecting optic 
stimulation to the maturation of retinal ganglion cell connectivity 
is mediated via GlyR synaptic transmission.
CONCLUSIONS AND FUTURE DIRECTIONS
As is apparent from the literature cited in the previous sections, 
the amino acid glycine, which serves as an essential inhibitory neu-
rotransmitter in the adult nervous system, also plays a myriad of 
important roles in neural development. While signiﬁ  cant progress 
has been made in elucidating the various roles of glycinergic sig-
naling during embryogenesis as well as the mechanisms by which 
neurons adopt this important neurotransmitter phenotype, recent 
ﬁ  ndings have raised new questions and opened fresh avenues 
of research.
For example, one area that is particularly ripe for future study 
and potentially very informative for the ﬁ  eld of glycinergic neu-
rotransmission is an integrative “evo-devo” approach that com-
bines expression data with analyses of upstream regulatory regions 
from an array of different species. The detailed analyses of the 
developmental expression patterns on the individual glycinergic 
phenotype markers have provided much of the necessary ground-
work for future comparative studies. Nevertheless, to close the 
gaps in our knowledge, a systematic and comparative analysis of 
glycine IR and GlyT2, VIAAT, and the GlyR on both the mRNA 
and protein level in each of the major model organisms would 
be informative. Additionally, to date, there has been little devel-
opmental analysis of glycinergic markers in non-model systems, 
an endeavor that would provide increased comparative richness. 
However, for an integrated understanding, expression studies from 
a variety of species should be combined with functional analyses of 
the upstream regulatory regions that govern the expression of the 
various domains of each of the glycinergic markers. Currently there 
are virtually no detailed analyses of the regulatory regions control-
ling the expression patterns of any of the glycinergic marker genes. 
The availability of sequenced genomes from a variety of species 
and programs such as PipMaker allows investigators to conduct 
powerful in silico analysis to identify regions of conservation in 
non-coding regions among divergent species, regions that may 
serve as important evolutionarily conserved regulatory control 
regions (Elnitski et al., 2003). While not a substitute for in vivo 
transgenic analysis which demonstrates that a given stretch of DNA 
drives a speciﬁ  c realm of expression, in silico analysis provides a 
means to conduct global comparative genomic analyses and can 
potentially identify important conserved regulatory regions, even 
hundreds of kilobases up- or downstream of the coding region. 
For example, 5 kb of DNA upstream of the X. laevis GlyT2 gene 
was compared to upstream sequences from X. tropicalis, zebraﬁ  sh, 
mouse and human in silico using PipMaker software. Three con-
served non-coding (CNC) regions were observed 4.7 kb, 2 kb, and 
200 bp upstream of the start site (unpublished data), suggesting a 
possible regulatory role. Understanding the regulation of “terminal 
differentiation” genes such as GlyT2 or VIAAT is a particularly 
interesting problem given that many genes associated with the 
differentiated phenotype display profoundly similar expression 
patterns across species, yet do not share signiﬁ  cant sequence simi-
larity in their regulatory regions. Although exact expression for 
glycinergic markers obviously differs among these organisms, the 
general pattern of expression timing and location is maintained 
between these groups. Further analysis of control regions of the 
glycinergic genes may shed light on this important issue in tran-
scriptional regulation as well as on the evolution of glycinergic 
signaling. Recent work has also questioned the previous view that 
glycinergic signaling is unique to the vertebrate lineage. Cloning 
and sequence analysis accompanied by careful expression data on 
both the mRNA and protein level from organisms representing 
a variety of different phyla should resolve this question and also 
address the broader evolutionary issue.
While analysis of regulatory regions has the potential to identify 
novel factors not yet known to be involved in glycinergic speciﬁ  ca-
tion, recent work has already identiﬁ  ed a number of factors known 
to be involved in this process. Additional analysis along the lines 
of Batista and Lewis (2008), Huang et al. (2008), and Joshi et al. 
(2009) on how these individual factors interact in a network will 
be essential; the use of chip and high throughput sequencing tech-
nologies to conduct more global analyses of gene expression during 
glycincergic speciﬁ  cation and following the inactivation of putative 
glycinergic regulatory genes will provide a more complete picture 
of the gene networks involved. However, these approaches must still 
be complemented by gene expression analysis at the single cell level, 
the level at which speciﬁ  cation is actually occurring. Indeed, one of 
the difﬁ  culties of glycinergic phenotype speciﬁ  cation is that many, 
if not all, of the identiﬁ  ed factors also serve as GABAergic speciﬁ  -
cation factors. This intriguing feature may also present a valuable 
clue to the underlying mechanism of determination, namely that 
cells initially co-express GABAergic and glycinergic determination 
factors as well as differentiation markers prior to selecting one or the 
other system, a hypothesis supported by co-expression data (Aubrey 
et al., 2007) and electophysiological data (Muller et al., 2006, 2008).
Interestingly, the developmental kinetics of glycine closely mirrors 
GABA in most of the phyla in which comparative expression stud-
ies have been conducted, with glycincergic neurons often, but not 
always, developing slightly later. Additional colocalization studies 
of glycinergic and GABAergic phenotype markers (as well as other 
neurotransmitter markers) throughout development on the single 
cell level are clearly indicated. These studies would be particularly 
useful if they are complemented with electrophysiological analy-
ses to determine if and when the gene expression correlates with 
functional synaptic signaling.
The relative roles of “hard-wired” transcriptional regulatory con-
trol versus activity-dependent mechanisms remain an important 
issue in glycinergic speciﬁ  cation and in neurotransmitter pheno-
type determination generally. Recent work has demonstrated that 
neurotransmitter speciﬁ  cation has an activity-dependent compo-
nent in which high levels of activity as evidenced by calcium spiking 
is associated with the development of inhibitory phenotypes and 
lower levels correlated with the formation of excitatory phenotypes. 
Whether activity-dependent mechanisms or hard-wired molecular 
switches are responsible for glycincergic determination requires 
additional research.
Equally important is the function of glycinergic signaling 
during development. Clearly the presynaptic role remains con-
troversial and understudied. Elucidation will require careful and 
sensitive expression assays for each of the components to ensure 
that the “machinery” is present, followed by rigorous functional Frontiers in Molecular Neuroscience  www.frontiersin.org  April 2010  | Volume 3  |  Article 11  |  11
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combined with functional assays including novel gene swapping 
experiments (along the lines of those conducted by Aubrey et al. 
(2007)) will provide an encompassing picture of how this impor-
tant phenotype is speciﬁ  ed and its numerous roles in the develop-
ment of the nervous systems.
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  perturbation experiments in multiple species. A recent study 
  showing that inhibitory and excitatory phenotypes may be medi-
ated by presynaptic GABA lend support to a possible presynaptic 
role for glycine (Root et al., 2008), however identiﬁ  cation of the 
molecular mechanisms, that is, the presence of a receptor, is essen-
tial. While the presynaptic role remains problematic, the role of 
glycine and glycinergic neurons in circuit and network develop-
ment has assumed a new importance. Continued functional studies 
employing conditional knockouts to identify new or early roles will 
continue to be informative. An integrated approach using detailed 
gene expression and electrophysiological methodologies as employ-
ing the tools of comparative genomics and “evo-devo” analysis 
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